Use of Nitric Oxide Synthase Inhibitors in Septic Shock

Moncada S. Palmer R M J Higgs E. A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–42.

Vallance P. Moncada S. Role of endogenous nitric oxide in septic shock. New Horiz 1993; 1: 77–87.

Rees D D Cellek S. Palmer R M J Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem Biophys Res Commun 1990; 173: 541–47.

Gray G A Schott C. Julou-Schaeffer G. Fleming I. Parratt J R Stoclet J-C. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 1991; 103: 1218–24.

Zembowicz A. Vane J. Induction of nitric oxide synthase activity by toxic shock syndrome toxin I in a macrophage-monocyte cell line. Proc Natl Acad Sci USA 1992; 89: 2051–55.

Hibbs J B Jr Taintor R R Vavrin Z. Rachlin E. M. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87–94.

Palmer R M J Bridge L. Foxwell N A Moncada S. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 1993; 105: 11–12.

Stadler J. Billiar T R Curran R D . Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 1991; 260: C910–C916.

Nguyen T. Nrunson D. Crespi C L . DNA damage and mutation in human cells exposed to nitric oxide. Proc Natl Acad Sci USA 1992; 89: 3030–34.

Beckman J S Beckman T W Chen J. . Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620–24.

Kilbourn R G Jubran A. Gross S S . Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172: 1132–38.

Thiemermann C. Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bcaterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990; 182: 591–95.

Hutcheson I R Whittle B J R Boughton-Smith N. K. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101: 815–20.

Boughton-Smith N K Evans S M Laszlo F. Whittle B J R Moncada S. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 1993; 110: 1189–95.

Moncada S. Higgs E. A. The L-arginine:nitric oxide pathway. N Engl J Med 1994; 329: 2002–2005.

Nava E. Palmer R M J Moncada S. Inhibition of nitric oxide in septic shock: How much is beneficial? Lancet 1991; 338: 1555–57.

Billiar R T Curran R D Harbrecht B G Stuehr D J Demetris A J Simmons R. L. Modulation of nitrogen oxide synthesis in vivo: NG-methyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leuk Biol 1990; 48: 565–69.

Wright C E Rees D D Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26: 48–57.

Radomski M W Vallance P. Whitley G. Foxwell N. Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine-induced nitric oxide. Cardiovasc Res 1993; 27: 1380–92.

Kubes P. Suzuki M. Granger D. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651–55.

De Belder A J Radomski M W Why H J F . Nitric oxide synthase activity in human myocardium. Lancet 1993; 341: 84–85.

Ochoa J B Udekwu A O Billiar T R . Nitrogen oxide levels in patients following trauma and during sepsis. Ann Surg 1991; 214: 621–16.

Hibbs J B Jr Westenfelder C. Taintor R. . Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992; 89: 867–77.

Petros A. Bennett D. Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557–58.

Lorente J A Landin L. De Pable R. . L-arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21: 1287–95.

Petros A. Lamb G. Leone A. Moncada S. Bennett D. Vallance P. Effect of a nitric oxide synthase inhibitor in patients with septic shock: A randomised study. Cardiovasc Res 1994; 28: 34–39.

Schneider F. Lutun P. Hasselmann M. Stuclet J-C Tempe J. D. Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 1992; 18: 309–11.

Geller D A Nussler A K Di Silvio M. . Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993; 90: 522–26.

Bogle R J Whitley G St J Soo S C Johnstone A P Vallance P. Effect of anti-fungal imidazoles on mRNA levels and enzyme activity of inducible nitric oxide synthase. Br J Pharmacol 1994; 111: 1257–61.

Gross S S Levi R. L. Tetrahydrobiopterin synthesis: An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle cells. J Biol Chem 1993; 26: 25722–29.

Mihae Y U Tomasa G. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor; in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993; 21: 1635–44.

Tilton R G Chang C. Hasan K S . Prevention of diabetic vascular dysfunction by guanidines; inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993; 42: 221–32.

Wu C C Chen S J Szabo C S Thiemermann C. Vane J. R. Inhibition of nitric oxide formation with aminoguanidine attenuates the delayed circulatory failure in endotoxic shock in the rat [Abstract]. Br J Pharmacol 1994 (in press).

Bogle R. MacAllister R. Whitley G. Vallance P. Uptake of NG monomethyl L-arginine (L-NMMA) by human vascular endothelial cells: Stimulation by cytokines and endotoxin. J Physiol 1994; 475: 63.